Related Experiment Video
Updated: Jun 27, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity
C T Higuchi1, M Sannomiya, F R Pavan
1Unesp, Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, Rodovia Araraquara-Jaú km 01, CEP 14801-902, Araraquara-SP, Brazil.
Abstract:
Bioassay-guided fractionation of the chloroform extract of Byrsonima fagifolia leaves led to the isolation of active antitubercular compounds alkane dotriacontane (Minimal Inhibitory Concentration-MIC, 62.5 μg mL(-1)), triterpenoids as bassic acid (MIC = 2.5 μg mL(-1)), α-amyrin acetate (MIC = 62.5 μg mL(-1)), a mixture of lupeol, α- and β-amyrin (MIC = 31.5 μg mL(-1)) and a mixture of lupeol, and acetates of α- and β-amyrin (MIC = 31.5 μg mL(-1)). The antimycobacterial activity was determined by the Microplate Alamar Blue Assay (MABA) and the structures of promising compounds were determined by spectroscopic analysis. This investigation constitutes the first report of a chemical and antitubercular study of apolar compounds from B. fagifolia Niedenzu (IK).
Related Concept Videos
Antifungal Agents
Drugs that Stabilize Microtubules
Bacterial Phylum Actinobacteria
Anthelminthic Agents
Antiviral Nucleoside Inhibitors
Inhibitors of Bacterial DNA Synthesis